The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Ketogenic Diet in Alzheimer’s Disease
Open accessAbstract
At present, the prevalence of Alzheimer’s disease, a devastating neurodegenerative disorder, is increasing. Although the mechanism of the underlying pathology is not fully uncovered, in the last years, there has been significant progress in its understanding. This includes: Progressive deposition of amyloid β-peptides in amyloid plaques and hyperphosphorylated tau protein in intracellular as neurofibrillary tangles; neuronal loss; and impaired glucose metabolism. Due to a lack of effective prevention and treatment strategy, emerging evidence suggests that dietary and metabolic interventions could potentially target these issues. The ketogenic diet is a very high-fat, low-carbohydrate diet, which has a fasting-like effect bringing the body into a state of ketosis. The presence of ketone bodies has a neuroprotective impact on aging brain cells. Moreover, their production may enhance mitochondrial function, reduce the expression of inflammatory and apoptotic mediators. Thus, it has gained interest as a potential therapy for neurodegenerative disorders like Alzheimer’s disease. This review aims to examine the role of the ketogenic diet in Alzheimer’s disease progression and to outline specific aspects of the nutritional profile providing a rationale for the implementation of dietary interventions as a therapeutic strategy for Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Hypothesized mechanisms through which ketogenic diet (KD) influence Alzheimer’s disease (AD) development. ↓—decreased; ↑—increased. Based on Reference [7].](https://figures.cochat.ai/paper-figures/6eeba66bf29e4531a99920a01e1f15fc/ketogenic-diet-in-alzheimers-disease-figure-1.jpg)
![Figure 2 Hypothetical pathways leading to the neuroprotective action of KD (based on References [50,108]). FA—fatty acids; GABA—γ-aminobutyric acid; PCr:Cr—phosphocreatine:creatine ratio; ROS—reactive oxygen species; UCP—uncoupling proteins; increase (↑) or decrease (↓)—arrows indicate the direction of the relationship between variables.](https://figures.cochat.ai/paper-figures/bac5284128dd4da9b9753c793f254924/ketogenic-diet-in-alzheimers-disease-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the neuroprotective effects of the ketogenic diet have also been reported in studies, which would benefit patients with Alzheimer’s or Parkinson’s disease [42,43].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 1×
“Cognitive deficits, resulting from the loss of neurons, are susceptible to neurofibrillary degeneration located in the limbic system, subcortical structures, archicortex and neocortex, and progressive synaptic dysfunction [4].”
BackgroundScheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777
The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., & Verdin, E. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00038-8 · Cited by 1,536
Cahill, G. F. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111258 · Cited by 1,319
Jasper's Basic Mechanisms of the Epilepsies
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.001.0001 · Cited by 1,143
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Cited by
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Raulin, A.-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C.-C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00574-4 · Cited by 756
Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 446
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 399
Ułamek-Kozioł, M., Czuczwar, S. J., Januszewski, S., & Pluta, R. (2019) · Nutrients · doi:10.3390/nu11102510 · Cited by 266
Self-citationChallenges and hopes for Alzheimer’s disease
Tatulian, S. A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.016 · Cited by 291
The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., et al. (2022) · Nutrients · doi:10.3390/nu14030668 · Cited by 225
Disorders of the enteric nervous system — a holistic view
Niesler, B., Kuerten, S., Demir, I. E., & Schäfer, K.-H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00385-2 · Cited by 196
Kong, C., Yan, X., Liu, Y., Huang, L., Zhu, Y., He, J., Gao, R., Kalady, M. F., Goel, A., Qin, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00549-9 · Cited by 200
Choi, Y. J., Jeon, S.-M., & Shin, S. (2020) · Nutrients · doi:10.3390/nu12072005 · Cited by 193
The Therapeutic Role of Ketogenic Diet in Neurological Disorders
Pietrzak, D., Kasperek, K., Rękawek, P., & Piątkowska‐Chmiel, I. (2022) · Nutrients · doi:10.3390/nu14091952 · Cited by 147
Marzia Perluigi, A., Domenico, F. D., Barone, E., & Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.025 · Cited by 134
Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
Jiang, Z., Yin, X., Wang, M., Chen, T., Wang, Y., Gao, Z., & Wang, Z. (2022) · Aging and Disease · doi:10.14336/ad.2021.1217 · Cited by 126
Global rural health disparities in Alzheimer's disease and related dementias: State of the science
Wiese, L. K., Gibson, A., Guest, M. A., Nelson, A. R., Weaver, R. H., Gupta, A., Carmichael, O. T., Lewis, J., Lindauer, A., Loi, S. M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13104 · Cited by 117
The Role of Diet and Dietary Patterns in Parkinson’s Disease
Knight, E., Geetha, T., Burnett, D. O., & Babu, J. R. (2022) · Nutrients · doi:10.3390/nu14214472 · Cited by 110
Napoleão, A., Fernandes, L., Miranda, C., & Marum, A. P. (2021) · Nutrients · doi:10.3390/nu13041302 · Cited by 103
Disentangling Mitochondria in Alzheimer’s Disease
Johri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111520 · Cited by 107
Ketogenic diet as a metabolic treatment for mental illness
Norwitz, N. G., Sethi, S., & Palmer, C. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000564 · Cited by 99
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
Toniolo, S., Sen, A., & Husain, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239318 · Cited by 103
Grammatikopoulou, M. G., Goulis, D. G., Gkiouras, K., Theodoridis, X., Gkouskou, K. K., Evangeliou, A., Dardiotis, E., & Bogdanos, D. P. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa073 · Cited by 99
The Expanding Role of Ketogenic Diets in Adult Neurological Disorders
McDonald, T. J. W., & Cervenka, M. C. (2018) · Brain Sciences · doi:10.3390/brainsci8080148 · Cited by 98
Vinciguerra, F., Graziano, M., Hagnäs, M. P., Frittitta, L., & Tumminia, A. (2020) · Nutrients · doi:10.3390/nu12041019 · Cited by 97
The Combined Influences of Exercise, Diet and Sleep on Neuroplasticity
Pickersgill, J. W., Turco, C. V., Ramdeo, K. R., Rehsi, R. S., Foglia, S. D., & Nelson, A. J. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.831819 · Cited by 100
Glucose metabolism, neural cell senescence and Alzheimer's disease
Wang, Q., Duan, L., Li, X., Wang, Y., Guo, W., Guan, F., & Ma, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084351 · Cited by 90
Role of mitochondria in physiological activities, diseases, and therapy
Wang, L., Zhou, X., & Lu, T. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00284-5 · Cited by 99
The Ketogenic Diet and Alzheimer's Disease
Hersant, H., & Grossberg, G. T. (2022) · The journal of nutrition health & aging · doi:10.1007/s12603-022-1807-7 · Cited by 84
Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases
Zhang, H., Tao, Y., & Leng, S. X. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220830102628 · Cited by 82
Semba, R. D. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa024 · Cited by 82
Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Potenza, M. A., Sgarra, L., Desantis, V., Nacci, C., & Montagnani, M. (2021) · Antioxidants · doi:10.3390/antiox10081257 · Cited by 87
Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models
Carranza-Naval, M. J., Vargas-Soria, M., Hierro‐Bujalance, C., Baena‐Nieto, G., García-Alloza, M., Infante‐Garcia, C., & del Marco, À. (2021) · Biomolecules · doi:10.3390/biom11020262 · Cited by 88
Lim, J.-M., Letchumanan, V., Tan, L. T., Hong, K., Wong, S. H., Mutalib, N. A., Lee, L., & Law, J. W. (2022) · Nutrients · doi:10.3390/nu14173566 · Cited by 76
Ketogenic Diet: A Review of Composition Diversity, Mechanism of Action and Clinical Application
Malinowska, D., & Żendzian‐Piotrowska, M. (2024) · Journal of Nutrition and Metabolism · doi:10.1155/2024/6666171 · Cited by 82
Ketogenic Diet for the Treatment and Prevention of Dementia: A Review
Davis, J. J., Fournakis, N. A., & Ellison, J. M. (2020) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720901785 · Cited by 73
Human gut microbiome, diet, and mental disorders
Borrego-Ruiz, A., & Borrego, J. J. (2024) · International Microbiology · doi:10.1007/s10123-024-00518-6 · Cited by 79
Kovács, Z., Brunner, B., & Ari, C. (2021) · Nutrients · doi:10.3390/nu13072197 · Cited by 76
Could very low-calorie ketogenic diets turn off low grade inflammation in obesity? Emerging evidence
Barrea, L., Caprio, M., Watanabe, M., Cammarata, G., Feraco, A., Muscogiuri, G., Verde, L., Colao, A., & Savastano, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2054935 · Cited by 68
Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
Raut, S., Bhalerao, A., Powers, M., Gonzalez, M., Mancuso, S., & Cucullo, L. (2023) · Cells · doi:10.3390/cells12162019 · Cited by 65
Cao, Y., Zhao, L.-W., Chen, Z.-X., & Li, S.-H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 65
Nutrition as Metabolic Treatment for Anxiety
Norwitz, N. G., & Naidoo, U. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.598119 · Cited by 73
Onaolapo, O. J., & Onaolapo, A. Y. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i28.8295 · Cited by 65
Torosyan, N., Sethanandha, C., Grill, J. D., Dilley, M., Lee, J., Cummings, J. L., Ossinalde, C., & Silverman, D. H. S. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.009 · Cited by 67
Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
Frausto, D. M., Forsyth, C. B., Keshavarzian, A., & Voigt, R. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736814 · Cited by 61
The Gut Microbiome–Brain Crosstalk in Neurodegenerative Diseases
Ghezzi, L., Cantoni, C., Rotondo, E., & Galimberti, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071486 · Cited by 64
Winiarska‐Mieczan, A., Baranowska‐Wójcik, E., Kwiecień, M., GRELA, E. R., Szwajgier, D., Kwiatkowska, K., & Kiczorowska, B. (2020) · Nutrients · doi:10.3390/nu12020435 · Cited by 61
Gut Microbiota and Alzheimer’s Disease: How to Study and Apply Their Relationship
Nguyen, N. M., Cho, J., & Lee, C.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044047 · Cited by 61
A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 62
Black, M., & Bowman, M. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.06.008 · Cited by 73
Roles and Mechanisms of Axon-Guidance Molecules in Alzheimer’s Disease
Zhang, L., Qi, Z., Li, J., Li, M., Du, X., Wang, S., Zhou, G., Xu, B., Liu, W., Xi, S., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02311-2 · Cited by 63
Campbell, I. H., & Campbell, H. J. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110299 · Cited by 63
Singh, S., Sahu, K., Kapil, L., Singh, C., & Singh, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07161-2 · Cited by 58
The Role of Ketogenic Metabolic Therapy on the Brain in Serious Mental Illness: A Review
Sethi, S., & Ford, J. M. (2022) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20220009 · Cited by 70
The Interaction of Diet and Mitochondrial Dysfunction in Aging and Cognition
Kaliszewska, A., Allison, J., Martini, M., & Arias, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073574 · Cited by 56
New Insights into Mitochondria in Health and Diseases
Li, Y., Zhang, H., Yu, C., Dong, X., Yang, F., Wang, M., Wen, Z., Su, M., Li, B., & Yang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189975 · Cited by 60
Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention
Saris, C. G. J., & Timmers, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.947567 · Cited by 52
Bohnen, J. L. B., Albin, R. L., & Bohnen, N. I. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1123290 · Cited by 52
Monda, A., Torre, M. E. L., Messina, A., Maio, G. D., Monda, V., Moscatelli, F., Stefano, M. D., Marra, M. L., di Padova, M., Dipace, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425816 · Cited by 51
Coconut oil as a therapeutic treatment for alzheimer's disease: a review
Sandupama, P., Munasinghe, D., & Jayasinghe, M. A. (2022) · Journal of Future Foods · doi:10.1016/j.jfutfo.2022.03.016 · Cited by 49
Ischemia as a common trigger for Alzheimer’s disease
Elman-Shina, K., & Efrati, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1012779 · Cited by 48
Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders
Mitra, S., Banik, A., Saurabh, S., Maulik, M., & Khatri, S. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0998-21.2022 · Cited by 49
Zhang, J., Xie, L., Cheng, C., Liu, Y., Zhang, X., Wang, H., Hu, J., Yu, H., & Xu, J. (2023) · Brain Imaging and Behavior · doi:10.1007/s11682-023-00804-3 · Cited by 51
Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions
Shen, W., He, J., Hou, T., Si, J., & Chen, S. (2022) · Aging and Disease · doi:10.14336/ad.2021.1208 · Cited by 45
Wang, H., Lv, Y., Ti, G., & Ren, G. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03607-1 · Cited by 44
Ketones: potential to achieve brain energy rescue and sustain cognitive health during ageing
Myette‐Côté, É., Soto-Mota, A., & Cunnane, S. C. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521003883 · Cited by 50
Aktary, N., Jeong, Y., Oh, S., Shin, Y., Sung, Y., Rahman, M., Santiago, L. R., Choi, J., Song, H. G., Nurkolis, F., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1601712 · Cited by 53
Kazemeini, S., Nadeem-Tariq, A., Shih, R., Rafanan, J., Ghani, N., & Vida, T. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111720 · Cited by 41
Ketogenic diet and multiple health outcomes: an umbrella review of meta-analysis
Chen, S., Su, X., Feng, Y., Li, R., Liao, M., Fan, L., Liu, J., Chen, S., Zhang, S., Cai, J., et al. (2023) · Nutrients · doi:10.3390/nu15194161 · Cited by 41
Skawratananond, S., Xiong, D. X., Zhang, C., Tonk, S. S., Pinili, A., Delacruz, B., Pham, P., Smith, S. C., Navab, R., & Reddy, P. H. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102732 · Cited by 42
The Implication of Physiological Ketosis on The Cognitive Brain: A Narrative Review
Altayyar, M., Nasser, J. A., Thomopoulos, D., & Bruneau, M. L. (2022) · Nutrients · doi:10.3390/nu14030513 · Cited by 45
Ticinesi, A., Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Rio, D. D., Ventura, M., Sgoifo, A., & Angelino, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215493 · Cited by 44
Makievskaya, C. I., Popkov, V. A., Andrianova, N. V., Liao, X., Zorov, D. B., & Plotnikov, E. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032576 · Cited by 41
Low-Carbohydrate High-Fat Diet: A SWOC Analysis
Nuwaylati, D. A., Eldakhakhny, B. M., Bima, A. I. H., Sakr, H. F., & Elsamanoudy, A. Z. (2022) · Metabolites · doi:10.3390/metabo12111126 · Cited by 42
Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases
Kuštrimović, N. Z., Balkhi, S., Bilato, G., & Mortara, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212164 · Cited by 45
Ketone Bodies and Brain Metabolism: New Insights and Perspectives for Neurological Diseases
López-Ojeda, W., & Hurley, R. A. (2023) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20230017 · Cited by 39
Dietary pattern and hepatic lipid metabolism
Zou, P., & Wang, L. (2023) · Liver Research · doi:10.1016/j.livres.2023.11.006 · Cited by 43
Gut–Brain Axis: Focus on Sex Differences in Neuroinflammation
Caldarelli, M., Rio, P., Marrone, A., Ocarino, F., Chiantore, M., Candelli, M., Gasbarrini, A., Gambassi, G., & Cianci, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105377 · Cited by 44
Ketogenic Diet and Cardiac Substrate Metabolism
Luong, T. V., Abild, C. B., Bangshaab, M., Gormsen, L. C., & Søndergaard, E. (2022) · Nutrients · doi:10.3390/nu14071322 · Cited by 41
Lilamand, M., Mouton‐Liger, F., Valentin, E. D., Ortiz, M. S., & Paquet, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.807970 · Cited by 37
Impact of the Ketogenic Diet on Neurological Diseases: A Review
Rubio, C., López-Landa, A., Parra, H. R., & Rubio‐Osornio, M. (2025) · Life · doi:10.3390/life15010071 · Cited by 39
Effects of caloric restriction on the antagonistic and integrative hallmarks of aging
Erbaba, B., Arslan-Ergül, A., & Adams, M. M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101228 · Cited by 37
Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
Miziak, B., Błaszczyk, B., & Czuczwar, S. J. (2021) · Pharmaceuticals · doi:10.3390/ph14050458 · Cited by 36
Self-citationPrevention of Alzheimer's disease through diet: An exploratory review
Bhuiyan, N. Z., Hasan, M. K., Mahmud, Z., Hossain, M. S., & Rahman, A. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100257 · Cited by 37
Diets, Gut Microbiota and Metabolites
Liu, Y., Zhong, W., Li, X., Shen, F., Ma, X., Yang, Q., Hong, S., & Sun, Y. (2023) · Phenomics · doi:10.1007/s43657-023-00095-0 · Cited by 36
Anderson, J., Ozan, E., Chouinard, V., Grant, G., Macdonald, A. A., Thakkar, L., & Palmer, C. (2024) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-024-00339-4 · Cited by 36
α-Tocopherol Protects Lipopolysaccharide-Activated BV2 Microglia
Torre, M. E. L., Cianciulli, A., Monda, V., Monda, M., Filannino, F. M., Antonucci, L., Valenzano, A. A., Cibelli, G., Porro, C., Messina, G., et al. (2023) · Molecules · doi:10.3390/molecules28083340 · Cited by 32
Damiano, F., Benedetto, G. E. D., Longo, S., Giannotti, L., Fico, D., Siculella, L., & Giudetti, A. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00783 · Cited by 32
Shahpasand, S., Khatami, S. H., Ehtiati, S., Alehossein, P., Salmani, F., Toutounchi, A. H., Zarei, T., Shahmohammadi, M. R., Khodarahmi, R., Aghamollaii, V., et al. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109693 · Cited by 34
Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?
Kim, C.-K., Sachdev, P. S., & Braidy, N. (2022) · Aging and Disease · doi:10.14336/ad.2021.0705 · Cited by 32
Neuroinflammation: Molecular Mechanisms And Therapeutic Perspectives
Meccariello, R., Marino, M., Mele, E., Pastorino, G. M. G., Operto, F. F., Santoro, A., & Viggiano, A. (2022) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524922666220929153215 · Cited by 30
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Kanwal, H., Sangineto, M., Ciarnelli, M., Castaldo, P., Villani, R., Romano, A. D., Serviddio, G., & Cassano, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074050 · Cited by 28
el‐Rady, N. M. A., Ahmed, A., Abdel‐Rady, M. M., & Ismail, O. I. (2020) · Physiological Reports · doi:10.14814/phy2.14651 · Cited by 31
Caron, J. P., Kreher, M. A., Mickle, A. M., Wu, S., Przkora, R., Estores, I. M., & Sibille, K. T. (2022) · Nutrients · doi:10.3390/nu14122536 · Cited by 31
Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease
Lee, D. D., Lee, V. M. ‐., & Hur, S. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1042865 · Cited by 28
Uddin, M. S., Kabir, M. T., Tewari, D., Mamun, A. A., Barreto, G. E., BUNGAU, S. G., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02065-3 · Cited by 28
Impairments in Brain Bioenergetics in Aging and Tau Pathology: A Chicken and Egg Situation?
Grimm, A. (2021) · Cells · doi:10.3390/cells10102531 · Cited by 26
Hammond, T. C., & Lin, A. (2022) · Journal of Cellular Immunology · doi:10.33696/immunology.4.128 · Cited by 29
Xiao, X., Yan, X., Liang, C., & Yang, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1772036 · Cited by 27
Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
Ahmed, M., Semreen, A. M., El‐Huneidi, W., Bustanji, Y. K., Abu‐Gharbieh, E., Alqudah, M. A. Y., Alhusban, A., Shara, M., Abuhelwa, A. Y., Soares, N. C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010348 · Cited by 27
The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy
Su, S., Ji, X., Li, T., Teng, Y., Wang, B., Han, X., & Zhao, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1291450 · Cited by 26
Oliveira, T. P. D., Morais, A. L. B., dos Reis, P. L. B., Palotás, A., & Vieira, L. B. (2023) · Metabolites · doi:10.3390/metabo14010025 · Cited by 25
The emerging role of the microbiome in Alzheimer's disease
Wasén, C., Simonsen, E., Ekwudo, M. N., Profant, M. R., & Cox, L. M. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.09.001 · Cited by 25
Ferraris, C., Guglielmetti, M., Neri, L. D. C. L., Allehdan, S., Albasara, J. M., Alawadhi, H. F., Trentani, C., Perna, S., & Tagliabue, A. (2023) · Foods · doi:10.3390/foods12091743 · Cited by 24
Metadata
- Authors
- Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J.
- Affiliations
- Medical University of Lublin (PL)
- Mossakowski Medical Research Institute, Polish Academy of Sciences (PL)
- Institute of Psychiatry and Neurology (PL)
- Corresponding author
- Pluta, Ryszard
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-08-09
- Volume
- 20
- Issue
- 16
- Pages
- 3892
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6720297
- OpenAlex
- W2968152726
- Cited by
- 319
- References
- 124
- Citations by year
- 2026: 21 · 2025: 39 · 2024: 52 · 2023: 63 · 2022: 65 · 2021: 49 · 2020: 25 · 2019: 3
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Uniwersytet Medyczny w Lublinie
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- ketogenic diet, Alzheimer's disease, ketone bodies, neuroprotection, amyloid plaques, tau hyperphosphorylation, neurofibrillary tangles, mitochondrial function, neuroinflammation, apoptosis, dietary intervention, glucose metabolism
- MeSH terms
- Neuroprotection, Alzheimer Disease, Animals, Humans, Amyloid beta-Peptides, tau Proteins, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.